
NJ Flexi Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Updated: 18 Sept 2026 • 9:13 am
Posted by:

NJ Flexi Cap Fund Direct Growth Plan is at a NAV of ₹13.36 as of 17 Sep 2026, with scheme AUM of ₹2,696 Cr. Its 1-year, 3-year and 5-year returns are -6.74%, 9.35% and 0%, respectively, and the fund sits in the High Risk category. Our view is that this is a fund for investors who can tolerate sharp short-term swings and are mainly looking at a diversified flexi-cap style exposure rather than a smooth return path.
The recent return pattern is weaker than the benchmark over 1 year, but the 3-year outcome is better than the benchmark and the portfolio is built around individual stock selection. That mix can help over longer periods, but the uneven short-term behaviour means it suits investors with a longer horizon and a clear comfort with volatility.
Quick facts
| Particular | Details |
|---|---|
| NAV | ₹13.36 as of 17 Sep 2026 |
| AUM | ₹2,696 Cr |
| Expense Ratio | 0.54% |
| Launch Date | 05 Sep 2023 |
| Min SIP | ₹100 |
| Risk Category | High Risk |
| Benchmark | Nifty 50 |
| Fund Category | Equity |
| Exit Load | Nil upto 5% of units and 1% for remaining units on or before 30D, Nil after 30D |
| Fund Managers | Dhaval Patel, Viral Shah, Jaimin Ilavia |
The fund is managed by Dhaval Patel, Viral Shah and Jaimin Ilavia.
Source data date: as of 17 Sep 2026
Performance
| Period | Fund return | Benchmark return |
|---|---|---|
| 1M | -3.75% | -3.66% |
| 3M | 0.45% | -3.71% |
| 1Y | -6.74% | -7.13% |
| 3Y | 9.35% | 5.82% |
| 5Y | Data not available | Data not available |
The last month and last quarter show a fund that has been uneven rather than steady. The 1-month figure is still negative, but the 3-month figure turned marginally positive while the benchmark stayed negative for that same period. That tells us the fund has been able to recover more quickly than the index in some recent stretches, even though the latest month remained soft.
Over one year, the fund is still in negative territory and only slightly ahead of the benchmark. That small gap matters more for comparison than for comfort, because both the fund and the benchmark struggled over the same period. The more useful picture appears over three years, where the fund has compounded better than the benchmark and suggests that stock selection has added value across a fuller cycle.
Because the scheme launched on 05 Sep 2023, a true five-year track record is not yet available. For investors, that means the longer-term case has to rely on the 3-year trend and the portfolio’s composition rather than on a full market-cycle history. Recent behaviour looks choppier than the 3-year outcome, so the fund’s shorter-term path still appears vulnerable to market swings.
Source data date: as of 17 Sep 2026
Should you BUY or HOLD NJ Flexi Cap?
A fund's past returns alone don't tell you whether you should buy it today or continue holding it.
The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.
Already holding NJ Flexi Cap? Thinking of investing now?
Peer comparison
| Fund | 1Y return | 3Y return | 5Y return |
|---|---|---|---|
| NJ Flexi Cap Fund Direct Growth Plan | -6.74% | 9.35% | Data not available |
| Bank of India Flexi Cap Fund Direct Growth Plan | 10.1% | 18.09% | 16.01% |
| ITI Flexi Cap Fund Direct Growth Plan | 9.54% | 17.61% | Data not available |
| Navi Flexi Cap Fund Direct Growth Plan | 7.9% | 10.18% | 10.89% |
| LIC MF Multi Cap Fund Direct Growth Plan | 7.11% | 17.04% | Data not available |
| Aditya Birla SL Flexi Cap Fund Direct Growth Plan | 5.94% | 13.33% | 10.98% |
This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.
The fund’s 1-year return trails every listed peer in this comparison set, which shows that the most recent stretch has been comparatively weak. That said, the 3-year figure is below the stronger peer group names but still ahead of the benchmark, so the longer view is more constructive than the one-year snapshot.
The peer set also shows a split story on longer windows. Some peers have a much stronger 3-year and 5-year record, while others have incomplete five-year histories. Against that backdrop, this scheme looks better when judged against the benchmark than when judged against the stronger peer returns. The result is a mixed comparison: the short-term gap is clear, but the medium-term profile is not without merit.
Source data date: as of 17 Sep 2026
Want to know more? Log in to Univest for more mutual fund insights.
Portfolio: where your money goes
| Holding | Sector | Weight |
|---|---|---|
| Torrent Pharmaceuticals Limited | Healthcare | 5.63% |
| Bosch Limited | Automobile & Ancillaries | 5.29% |
| DR. Lal Path Labs Limited | Healthcare | 4.58% |
| Eicher Motors Limited | Automobile & Ancillaries | 4.49% |
| ICICI Bank Limited | Bank | 4.39% |
| Marico Limited | FMCG | 4.22% |
| Britannia Industries Limited | FMCG | 3.96% |
| Cipla Limited | Healthcare | 3.65% |
| Sun Pharmaceutical Industries Limited | Healthcare | 3.63% |
| Alkem Laboratories Limited | Healthcare | 3.23% |
The largest holding is Torrent Pharmaceuticals Limited at 5.63%, so no single stock dominates the portfolio on its own. The drop from the first holding to the tenth is gradual rather than abrupt, moving from 5.63% to 3.23%, which suggests the visible book is spread across several positions instead of hinging on one very large bet.
The top 10 holdings account for approximately 43.07% of the portfolio, and the scheme discloses 47 holdings in total. That combination suggests the remaining positions form a meaningful tail, so the fund may have influence from a broad set of ideas even though the largest names still matter. The current mix also leans toward healthcare, automobiles and consumer-facing businesses, which can create a fairly active stock-specific return pattern.
Given the concentration in the displayed holdings is moderate rather than extreme, the portfolio may still behave differently from a plain index fund. The presence of 47 disclosed holdings means the fund is not dependent on only a handful of stocks, but the top names are large enough to matter if any one theme moves sharply.
To see all holdings, visit the NJ Flexi Cap Fund Direct Growth Plan page
Source data date: as of 17 Sep 2026
Who should invest
This fund suits investors who can stay invested through uneven returns and who are comfortable with a High Risk profile. The 1-year decline and the stronger 3-year outcome together suggest that the fund can be volatile over shorter windows but may reward patience over a longer horizon.
The benchmark comparison and the peer comparison point to a simple trade-off: the recent stretch has been weaker than the stronger peer names, but the 3-year number is still better than the benchmark. Investors who want steadier near-term outcomes may find the path uncomfortable, while those who can accept swings for the possibility of better medium-term compounding may find the profile more relevant.
Tax and exit load
| Holding period | Tax rate | Description |
|---|---|---|
| Units held less than 1 year | 20% | Short-term capital gains tax |
| Units held more than 1 year | 12.5% | Long-term capital gains tax |
Exit load: Nil up to 5% of units and 1% for remaining units on or before 30 days; no exit load after the holding period.
Source data date: as of 17 Sep 2026
Frequently asked questions
What is the current NAV of NJ Flexi Cap Fund Direct Growth Plan?
The NAV is ₹13.36 as of 17 Sep 2026.
What are the fund’s 1-year, 3-year and 5-year returns?
The 1-year return is -6.74%, the 3-year return is 9.35%, and the 5-year return is Data not available because the scheme has not completed that track record.
How has the fund performed against its benchmark?
Over 1 year it is slightly ahead of the benchmark, while over 3 years it is ahead by a wider margin. The recent one-month reading is still negative, so the short-term picture remains less stable than the 3-year trend.
How does it compare with the peer funds listed here?
Its 1-year return is weaker than the listed peer funds, while its 3-year return is below the stronger peer names but still ahead of the benchmark. That gives it a mixed peer profile rather than a uniformly strong one.
What is the minimum SIP amount?
The minimum SIP amount is ₹100.
Who manages the fund and what is the exit load?
The fund is managed by Dhaval Patel, Viral Shah and Jaimin Ilavia. The exit load is nil up to 5% of units and 1% for the remaining units on or before 30 days, with no exit load after the holding period.
Bottom line
NJ Flexi Cap Fund Direct Growth Plan has a weaker recent stretch than its longer 3-year record, so the short-term picture does not fully match the medium-term outcome. It also compares less favourably with the stronger peer returns on 1-year and 3-year numbers, even though it stays ahead of the benchmark over 3 years. The portfolio is spread across 47 holdings, with no single stock taking over the book, which may help balance the fund’s stock-specific swings. It fits investors who can accept High Risk exposure and wait for the longer view to matter.
Published on 18 September 2026 at 9:11 AM IST
Explore mutual funds with Univest
Review mutual fund data, compare performance and explore fund insights on Univest.
RIA disclosure
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.
Recent Articles

DynaSIF Equity Long-Short Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

ICICI Pru Nifty Pharma Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

iSIF Equity Ex-Top 100 Long-Short Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

Union Multicap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
DynaSIF Equity Long-Short Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
ICICI Pru Nifty Pharma Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
iSIF Equity Ex-Top 100 Long-Short Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Union Multicap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
iSIF Hybrid Long-Short Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Popular this week
Bandhan CRISIL IBX 90:10 SDL Plus Gilt - Sep 2027 Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





